Effect of Different Grafting Material Following Surgically Facilitated Orthodontics Therapy

NCT06627829 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-10-04

No results posted yet for this study

Summary

The purpose of this study is to quantitatively investigate the radiographic changes of alveolar bone, and gingival tissue changes of the mandibular anterior teeth in experimental group A receiving SFOT using freeze-dried allograft with a collagen membrane, experimental group B receiving SFOT using particulate xenograft covered by a collagen membrane and control group receiving only orthodontics therapy.

Conditions

  • Malocclusion, Angle Class I

Interventions

DEVICE

Surgically facilitated orthodontics therapy (SFOT) using allograft

Participants will receive Surgically facilitated orthodontics therapy (SFOT) along with bone grafting using particulate allograft and collagen membrane, prior to orthodontics treatment.

DEVICE

Surgically facilitated orthodontics therapy (SFOT) using xenograft

Participants will receive SFOT using particulate xenograft and collagen membrane, prior to orthodontics treatment.

DEVICE

Usual care

Participants will have conventional orthodontics treatment with Invisalign aligners, without any surgical intervention

Sponsors & Collaborators

  • American Academy of Periodontology Foundation

    collaborator UNKNOWN
  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Sahar Dowlatshahi, DDS, MMSc · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2026-01-06
Completion
2027-01-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627829 on ClinicalTrials.gov